Ploumis Passadakis

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis

Ioannis Kourtzelis, Maciej M. Markiewski, Michael Doumas et al. · Blood · 2010 · 139 citations

Medicine, Immunology, Nephrology +14

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention

Dimitrios Tziakas, Georgios Chalikias, Dimitrios Stakos et al. · International Journal of Cardiology · 2011 · 83 citations

Medicine, Cardiology, Radiology +16